Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-11-01
|
| Series: | Genes and Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304225000984 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226940910665728 |
|---|---|
| author | Rodriguez-Jimenez Francisco Javier Artero-Castro Ana Studenovska Hana Selles Francisca Arteaga Claramunt Alba Maria Brymova Anna Jendelova Pavla Motlik Jan Petrovski Goran Lytvynchuk Lyubomyr Ardan Taras Tichotová Lucie Drutovič Saskia Sharma Ruchi Lukovic Dunja Bharti Kapil Erceg Slaven |
| author_facet | Rodriguez-Jimenez Francisco Javier Artero-Castro Ana Studenovska Hana Selles Francisca Arteaga Claramunt Alba Maria Brymova Anna Jendelova Pavla Motlik Jan Petrovski Goran Lytvynchuk Lyubomyr Ardan Taras Tichotová Lucie Drutovič Saskia Sharma Ruchi Lukovic Dunja Bharti Kapil Erceg Slaven |
| author_sort | Rodriguez-Jimenez Francisco Javier |
| collection | DOAJ |
| format | Article |
| id | doaj-art-7bbf34b653e14c50902f9c4ee2209b58 |
| institution | Kabale University |
| issn | 2352-3042 |
| language | English |
| publishDate | 2025-11-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Genes and Diseases |
| spelling | doaj-art-7bbf34b653e14c50902f9c4ee2209b582025-08-24T05:13:04ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422025-11-0112610160910.1016/j.gendis.2025.101609Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapyRodriguez-Jimenez Francisco Javier0Artero-Castro Ana1Studenovska Hana2Selles Francisca3Arteaga Claramunt Alba Maria4Brymova Anna5Jendelova Pavla6Motlik Jan7Petrovski Goran8Lytvynchuk Lyubomyr9Ardan Taras10Tichotová Lucie11Drutovič Saskia12Sharma Ruchi13Lukovic Dunja14Bharti Kapil15Erceg Slaven16Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Principe Felipe (CIPF), Valencia 46012, SpainStem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Principe Felipe (CIPF), Valencia 46012, SpainInstitute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague 16206, Czech RepublicStem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Principe Felipe (CIPF), Valencia 46012, SpainStem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Principe Felipe (CIPF), Valencia 46012, SpainInstitute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech RepublicInstitute of Experimental Medicine, Czech Academy of Sciences, Department of Neuroregeneration, Prague 14220, Czech RepublicInstitute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech RepublicCenter for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0450, Norway; Department of Ophthalmology, University of Split School of Medicine and University Hospital Centre, Split 21000, Croatia; Department of Ophthalmology, Oslo University Hospital, Oslo 0450, NorwayDepartment of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, Giessen 35392, Germany; Karl Landsteiner Institute for Retinal Research and Imaging, Vienna 1030, AustriaInstitute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech RepublicInstitute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech RepublicInstitute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech RepublicOcular and Stem Cell Translational Research Section, National Eye Institute, NIH, Bethesda, MD 20892, USADepartment of Animal Production and Health, Public Veterinary Health and Food Science and Technology, School of Veterinary Medicine; Universidad Cardenal Herrera-CEU, CEU Universities, C/ Assegadors nº 2 Alfara del Patriarca, 46115 Valencia, SpainOcular and Stem Cell Translational Research Section, National Eye Institute, NIH, Bethesda, MD 20892, USAStem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Principe Felipe (CIPF), Valencia 46012, Spain; National Stem Cell Bank-Valencia Node, Research Centre Principe Felipe, c/Eduardo Primo Yúfera 3, Valencia 46012, Spain; Corresponding author. Stem Cells Therapies in Neurodegenerative Diseases Lab, Research Center “Principe Felipe”, c/Eduardo Primo Yufera 3, Valencia 46012, Spain.http://www.sciencedirect.com/science/article/pii/S2352304225000984 |
| spellingShingle | Rodriguez-Jimenez Francisco Javier Artero-Castro Ana Studenovska Hana Selles Francisca Arteaga Claramunt Alba Maria Brymova Anna Jendelova Pavla Motlik Jan Petrovski Goran Lytvynchuk Lyubomyr Ardan Taras Tichotová Lucie Drutovič Saskia Sharma Ruchi Lukovic Dunja Bharti Kapil Erceg Slaven Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy Genes and Diseases |
| title | Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy |
| title_full | Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy |
| title_fullStr | Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy |
| title_full_unstemmed | Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy |
| title_short | Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy |
| title_sort | restored phagocytic ability of rpe patches derived from gene corrected retinitis pigmentosa hipscs on a biodegradable scaffold via clinical grade protocol implications for autologous therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2352304225000984 |
| work_keys_str_mv | AT rodriguezjimenezfranciscojavier restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT arterocastroana restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT studenovskahana restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT sellesfrancisca restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT arteagaclaramuntalbamaria restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT brymovaanna restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT jendelovapavla restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT motlikjan restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT petrovskigoran restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT lytvynchuklyubomyr restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT ardantaras restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT tichotovalucie restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT drutovicsaskia restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT sharmaruchi restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT lukovicdunja restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT bhartikapil restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy AT ercegslaven restoredphagocyticabilityofrpepatchesderivedfromgenecorrectedretinitispigmentosahipscsonabiodegradablescaffoldviaclinicalgradeprotocolimplicationsforautologoustherapy |